Abstract
Alexis C. Geppner, MLS, CTTS, PA-C, of The University of Texas MD Anderson Cancer Center, discusses key data from a session on hyper-CVAD and additional therapies for patients with acute lymphoblastic leukemia presented by Elias Jabbour, MD, also of MD Anderson Cancer Center, at the 2021 SOHO Annual Meeting.
